Trial intelligence / Profile preview

Safety and Efficacy of Prednisolone in Adrenal Insufficiency Disease (PRED-AID Study)

2018-001502-28Phase 3Unknown

Sponsor
Imperial College London
Start
Nov 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of prednisolone in hypoadrenocorticism (2 arms), sponsored by Imperial College London. Primary endpoint: Bone health. Status: unknown.

02

Drugs

prednisolone
03

Conditions

hypoadrenocorticism

Beyond the preview

Go deeper on 2018-001502-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-001502-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call